Metastatic Kidney Cancer: Signs, Causes, And How To Treat

Metastatic kidney cancer, also known as advanced renal cell carcinoma, occurs when cancerous cells from the kidney spread to other parts of the body. The main cause of metastatic kidney cancer is the uncontrolled growth of abnormal cells in the kidney, forming a tumor that can eventually metastasize to distant organs and tissues.

Factors such as smoking, obesity, high blood pressure, and family history of kidney cancer may increase the risk of developing this aggressive form of cancer. Understanding the nature of metastatic kidney cancer and its possible causes can help individuals make informed decisions about their health and seek appropriate medical advice for early detection and treatment.

What Are the Symptoms of Metastatic Kidney Cancer

Metastatic kidney cancer can present with various symptoms that can affect different parts of the body. Common signs may include persistent pain in the back or side, unexplained weight loss, fatigue, blood in the urine, and swelling in the legs and ankles.

As the cancer spreads to other organs, patients may experience additional symptoms such as shortness of breath, coughing up blood, bone pain, and neurological issues like headaches or weakness. It is essential to consult a healthcare provider if experiencing any concerning symptoms for proper evaluation and management.

Blood in urine, also known as hematuria, is a common symptom of metastatic kidney cancer.
Unexplained weight loss can be a sign of advanced kidney cancer spreading to other parts of the body.
Persistent pain in the back or side that doesn't go away can indicate metastatic kidney cancer.
Fatigue and weakness that are not relieved by rest may be experienced by individuals with metastatic kidney cancer.
Swelling in the legs and ankles, called edema, can occur as a result of kidney cancer spreading.

Get a second opinion from trusted experts and makeconfident, informed decisions.

Get Second Opinion

Causes of Metastatic Kidney Cancer

The primary cause of metastasis is the ability of cancerous cells to break away from the original tumor, travel through the bloodstream or lymphatic system, and establish new tumors in distant organs. Factors that contribute to the spread of kidney cancer include the tumor's size and stage at diagnosis, as well as the aggressiveness of the cancer cells. Additionally, genetic mutations and certain risk factors like smoking, obesity, and high blood pressure can increase the likelihood of metastatic kidney cancer development.

Metastatic kidney cancer can be caused by the spread of cancer cells from the primary kidney tumor to distant organs.
Smoking is a significant risk factor for developing kidney cancer, including the metastatic form that affects other body parts.
Genetic factors, such as inherited syndromes like von Hippel-Lindau disease, can predispose individuals to metastatic kidney cancer.
Exposure to certain environmental toxins and chemicals, like asbestos and cadmium, may increase the risk of metastatic kidney cancer.
Chronic conditions like obesity and high blood pressure can contribute to the development and progression of metastatic kidney cancer.

Types Of Metastatic Kidney Cancer

Other types include papillary renal cell carcinoma, chromophobe renal cell carcinoma, collecting duct carcinoma, and renal medullary carcinoma. Each type of metastatic kidney cancer has distinct features that may impact treatment approaches and outcomes. It is essential for healthcare providers to accurately identify the specific type of kidney cancer to tailor the most effective treatment plan for each individual patient.

Clear cell renal cell carcinoma is the most common type of metastatic kidney cancer.
Papillary renal cell carcinoma is the second most common subtype of metastatic kidney cancer.
Chromophobe renal cell carcinoma is a rare subtype of metastatic kidney cancer.
Sarcomatoid renal cell carcinoma is an aggressive form of metastatic kidney cancer.
Collecting duct carcinoma is a rare and aggressive type of metastatic kidney cancer.
Renal medullary carcinoma is a rare and aggressive subtype of metastatic kidney cancer, often associated with sickle cell trait.
MiT family translocation renal cell carcinoma is a rare subtype of metastatic kidney cancer that mainly affects young adults.

Risk Factors

Several risk factors can increase the likelihood of developing metastatic kidney cancer. These include smoking, obesity, high blood pressure, and a family history of the disease. Additionally, certain genetic conditions such as von Hippel-Lindau disease or hereditary papillary renal cell carcinoma can predispose individuals to this aggressive form of cancer. Regular screening and early detection are crucial for managing the risk of metastatic kidney cancer and improving treatment outcomes.

Smoking tobacco is a significant risk factor for metastatic kidney cancer, increasing the likelihood of developing the disease.
Obesity is associated with a higher risk of metastatic kidney cancer, as excess body weight can promote cancer growth.
High blood pressure, especially when uncontrolled, can contribute to the development and progression of metastatic kidney cancer.
Family history of kidney cancer or certain genetic syndromes can elevate the risk of developing metastatic kidney cancer.
Exposure to certain environmental toxins or chemicals, such as asbestos or cadmium, may increase the risk of metastatic kidney cancer.

Your health is everything - prioritize your well-being today.

Schedule Your Appointment

Diagnosis of Metastatic Kidney Cancer

Imaging tests such as CT scans, MRIs, and PET scans are commonly used to visualize the extent of cancer spread. A biopsy is often performed to confirm the presence of cancer cells in the affected organs. Blood tests may also be conducted to assess kidney function and overall health status.

Additionally, genetic testing may be recommended to help guide treatment decisions. By integrating these various diagnostic methods, healthcare professionals can accurately determine the stage of metastatic kidney cancer and develop a personalized treatment plan for the patient.

Imaging tests like CT scans and MRIs are commonly used to diagnose metastatic kidney cancer.
Biopsies may be performed to confirm the presence of cancer cells in distant sites.
Blood tests can help assess kidney function and detect potential biomarkers associated with metastatic disease.
PET scans are sometimes utilized to identify metastases in other organs or tissues.
A thorough physical examination by a healthcare provider is essential in evaluating a patient for metastatic kidney cancer.

Treatment for Metastatic Kidney Cancer

Metastatic kidney cancer treatment options typically involve a multidisciplinary approach tailored to each patient's specific needs. Common treatments may include surgery to remove the primary tumor or metastases, targeted therapy to attack cancer cells while sparing normal cells, immunotherapy to boost the body's immune response against cancer, radiation therapy to shrink tumors or relieve symptoms, and chemotherapy in certain cases. Clinical trials may also offer new and innovative treatment options for metastatic kidney cancer patients. The goal of treatment is often to control the cancer, alleviate symptoms, and improve quality of life. Regular monitoring and follow-up care are essential to track the response to treatment and adjust the plan as needed.

Treatment options for metastatic kidney cancer may include targeted therapy, which aims to block specific pathways involved in cancer growth and spread, such as drugs that target the vascular endothelial growth factor (VEGF) or mammalian target of rapamycin (mTOR) pathways.
Immunotherapy is another approach utilized in the treatment of metastatic kidney cancer, involving the use of medications that stimulate the immune system to recognize and attack cancer cells.
Chemotherapy, though less commonly used in kidney cancer, may be considered in certain cases to help slow cancer growth or relieve symptoms.
Surgery may be an option for some patients with metastatic kidney cancer, particularly if the cancer has spread to limited areas and can be safely removed.
Radiation therapy may be used to

Find Our Specialists

Book Doctor Appointment